Octagon is developing new medicines for autoimmune and inflammatory disease. The company is pioneering a selective immunomodulation approach based on glyco-immune checkpoint receptors that allows for precise targeting of disease-driving immune processes.
View Top Employees from Octagon TherapeuticsWebsite | http://octagontx.com |
Employees | 12 (5 on RocketReach) |
Founded | 2017 |
Industry | Biotechnology Research |
Looking for a particular Octagon Therapeutics employee's phone or email?
Isaac Stoner is the CEO of Octagon Therapeutics.
5 people are employed at Octagon Therapeutics.